The turbulence surrounding Jack Ma has now spread to his private equity firm.
Credit: Yunfeng Capital
It’s been a turbulent few months for Alibaba founder Jack Ma, ever since the Chinese government abruptly halted the initial public offering of his financial company Ant Group. Some of that turbulence has now spread to Yunfeng Capital, the private equity firm Ma set up in 2010 which has invested in some of China’s fastest-growing companies.
At The Wire, we periodically focus on prominent firms investing in China, introducing them to our readers and mapping their corporate and shareholding
Exclusive longform investigative journalism, Q&As, news and analysis, and data on Chinese business elites and corporations. We publish China scoops you won't find anywhere else.
A weekly curated reading list on China from Andrew Peaple.
A daily roundup of China finance, business and economics headlines.
We offer discounts for groups, institutions and students. Go to our Subscriptions page for details.
At the height of the pandemic, Chinese vaccine maker Sinovac was a hero and one of the country’s most promising companies. But its success masked a protracted dispute between rival investors and management for control of the cash-rich company. The Wire China investigates what went wrong.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OKPrivacy policy
